3.37
0.27 (8.71%)
0.27 (8.71%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.08
High
8.96
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.27 | 8.71% | 3.37 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.15 | 3.07 | 3.47 | 3.12 | 3.10 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.30 | 3.37 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,472 | 932,264 | $ 3.27 | $ 3,049,910 | - | 2.08 - 8.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:04:14 | formt | 100 | $ 3.37 | USD |
Period:
Draw Mode:
Cyclerion Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 145.84M | 43.28M | 35.86M | $ 2.30M | $ - | -2.57 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.96M | 6.30% |
Cyclerion Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYCN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.09 | 3.4899 | 2.82 | 3.11 | 498,592 | 0.28 | 9.06% |
| 1 Month | 2.73 | 3.4899 | 2.70 | 3.11 | 289,187 | 0.64 | 23.44% |
| 3 Months | 3.97 | 4.23 | 2.70 | 3.54 | 565,981 | -0.60 | -15.11% |
| 6 Months | 4.19 | 4.86 | 2.08 | 3.47 | 911,982 | -0.82 | -19.57% |
| 1 Year | 7.72 | 8.96 | 2.08 | 3.68 | 768,085 | -4.35 | -56.35% |
| 3 Years | 14.64 | 19.89 | 1.69 | 4.15 | 531,724 | -11.27 | -76.98% |
| 5 Years | 14.64 | 19.89 | 1.69 | 4.15 | 531,724 | -11.27 | -76.98% |
Cyclerion Therapeutics Description
| Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. |
